Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Avacta Group Share News (AVCT)
AVCT Share
Price
AVCT Share
News
AVCT Share
Chat51
AVCT Share
Trades258
AVCT
Live RNS
AVCT Share
Charts
AVCT Level 2
Console
AVCT Live
Share Price
AVCT Broker
Ratings
AVCT Directors
Deals
AVCT Financial
Diary
AVCT
Fundamentals
AVCT Short
Positions
AVCT
Media
AVCT Company
Research
AVCT Company
Timeline
Avacta Group Information
Share Price Information for Avacta Group (AVCT)
Share Price is delayed by 15 minutes
Get Live Data
70.00
0.00 (0.00%)
Bid:
69.00
Ask:
71.00
Spread:
2.00 (2.899%)
Market Cap:
£318.58m
Last checked at -
Last checked at 
Intraday Avacta Group Share Chart
Avacta Group News
30 Sep 2021
Avacta hails "transformative" first half despite widening loss
Avacta hails "transformative" first half despite widening loss
30 Sep 2021
Avacta losses widen as development spend increases
(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group reported cash and short-term deposits of £37m at the end of its first ha...
29 Sep 2021
Avacta sees pre-clinical development milestone in LG Chem partnership
Avacta sees pre-clinical development milestone in LG Chem partnership
29 Sep 2021
Avacta gets undisclosed milestone payment from LG Chem
(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Wednesday that a preclinical development milestone has been achi...
23 Sep 2021
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
2 Sep 2021
IN BRIEF: Avacta hires oncology drug developer as therapeutics CSO
IN BRIEF: Avacta hires oncology drug developer as therapeutics CSO
18 Aug 2021
IN BRIEF: Avacta hires cancer doctor Mark Goldberg for board
IN BRIEF: Avacta hires cancer doctor Mark Goldberg for board
11 Aug 2021
Avacta doses first patient in chemotherapy medication trial
Avacta doses first patient in chemotherapy medication trial
Follow the stocks
